CAS: 864082-47-3 - N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide
Formula:C21H16F4N4O2
- Synonyms:
- Gsk429286A
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK-429286 REF: 7W-GL0956CAS: 864082-47-3 | - - - | 256.00 €~606.00 € | Mon 10 Feb 25 |
 | GSK429286A REF: TM-T2633CAS: 864082-47-3 | 97.68% - 98.42% | 41.00 €~348.00 € | Mon 10 Feb 25 |
 | GSK 429286 REF: 3D-FF43356CAS: 864082-47-3 | Min. 98 Area-% | 301.00 €~840.00 € | Mon 17 Mar 25 |
 | GSK429286A REF: IN-DA00GRUUCAS: 864082-47-3 | 98% | - - - | Discontinued product |
Ref: 7W-GL0956
| 1mg | 256.00 € | ||
| 5mg | 418.00 € | ||
| 10mg | 606.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
GSK429286A
CAS:864082-47-3
GSK429286A (RHO-15) is a specific inhibitor of ROCK1/2 (IC50: 14/63 nM).
Formula:
C21H16F4N4O2
Purity:
97.68% - 98.42%
Color and Shape:
Solid
Molecular weight:
432.37
Ref: TM-T2633
| 2mg | 41.00 € | ||
| 5mg | 66.00 € | ||
| 10mg | 97.00 € | ||
| 25mg | 134.00 € | ||
| 50mg | 206.00 € | ||
| 100mg | 348.00 € | ||
| 1mL*10mM (DMSO) | 69.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
GSK 429286
CAS:864082-47-3
Inhibitor of ROCK1 kinase
Formula:
C21H16F4N4O2
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
432.37 g/mol
Ref: 3D-FF43356
| 10mg | 301.00 € | ||
| 50mg | 840.00 € |
Estimated delivery in United States, on Monday 17 Mar 2025
GSK429286A
CAS:864082-47-3
Formula:
C21H16F4N4O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
432.3710
Ref: IN-DA00GRUU
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
